FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Rob van Klaveren

Research Profile

Disorders

Procedures

Concepts & Ideas

Activities & Behaviors

Smoking

Geographic Areas

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Wieneke A Buikhuisen; Jacobus A Burgers; Frank Lj Custers; Steven Jm Gans; Harry Jm Groen; Catharina M Korse; Anna K Nowak; Nick Pavlakis; J Hugo Schouwink; Franz Mnh Schramel; Wim Fm Strankinga; Rob J van Klaveren; Andrew D Vincent; Paul Baas
Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study.
N Horeweg; J-W J Lammers; W Mali; Kristiaan Nackaerts; M Oudkerk; Rob J van Klaveren; C Weenink; H J M Groen; Harry J de Koning
Blinded and uniform cause of death verification in a lung cancer CT screening trial.
Susan C Van't Westeinde; Carla Weenink; Paul De Leyn; Harry J M Groen; Nanda Horeweg; Jan-Willem J Lammers; Kristiaan Nackaerts; Rob J van Klaveren
Complications following lung surgery in the Dutch-Belgian randomized lung cancer screening trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Rob van Klaveren (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Wieneke A Buikhuisen; Jacobus A Burgers; Frank Lj Custers; Steven Jm Gans; Harry Jm Groen; Catharina M Korse; Anna K Nowak; Nick Pavlakis; J Hugo Schouwink; Franz Mnh Schramel; Wim Fm Strankinga; Rob J van Klaveren; Andrew D Vincent; Paul Baas
Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study.
The lancet oncology 2013;14(6):543-51.
2012: N Horeweg; J-W J Lammers; W Mali; Kristiaan Nackaerts; M Oudkerk; Rob J van Klaveren; C Weenink; H J M Groen; Harry J de Koning
Blinded and uniform cause of death verification in a lung cancer CT screening trial.
Lung cancer (Amsterdam, Netherlands) 2012;77(3):522-5.
2012: Susan C Van't Westeinde; Carla Weenink; Paul De Leyn; Harry J M Groen; Nanda Horeweg; Jan-Willem J Lammers; Kristiaan Nackaerts; Rob J van Klaveren
Complications following lung surgery in the Dutch-Belgian randomized lung cancer screening trial.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2012;42(3):420-9.
2012: Susan C van 't Westeinde; René M Vernhout; Carla Weenink; Harry J de Koning; Harry J M Groen; Nanda Horeweg; Jan-Willem J Lammers; Willem Mali; Kristiaan Nackaerts; Matthijs Oudkerk; Frederik B Thunnissen; Rob J van Klaveren
The role of conventional bronchoscopy in the workup of suspicious CT scan screen-detected pulmonary nodules.
Chest 2012;142(2):377-84.
2012: C M van der Aalst; C A van Iersel; Rob J van Klaveren; P A de Jong; Jacques Fracheboud; F J M Frenken; Suzie J Otto; M Oudkerk; Harry J de Koning
Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-selection play a role?
Lung cancer (Amsterdam, Netherlands) 2012;77(1):51-7.
2012: Carlijn M van der Aalst; Harry J de Koning; Karien A M van den Bergh; Marc C Willemsen; Rob J van Klaveren
The effectiveness of a computer-tailored smoking cessation intervention for participants in lung cancer screening: a randomised controlled trial.
Lung cancer (Amsterdam, Netherlands) 2012;76(2):204-10.
2012: Joost J Nuyttens; Peter M Pattynama; John Praag; Noelle C van der Voort van Zyp; Rob J van Klaveren; Cornelis Verhoef; Shafak Aluwini; Mischa S Hoogeman
Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2012;102(3):383-7.
2012: Ingrid Broodman; Dominique de Costa; Lennard J M Dekker; Jan Lindemans; Christoph Stingl; Rob J van Klaveren; Martijn M VanDuijn; Theo M Luider
Mass spectrometry analyses of κ and λ fractions result in increased number of complementarity-determining region identifications.
Proteomics 2012;12(2):183-91.
2011: F A A Mohamed Hoesein; B van Ginneken; Rob J van Klaveren; Pieter Zanen; J-W J Lammers
Association of the transfer coefficient of the lung for carbon monoxide with emphysema progression in male smokers.
The European respiratory journal 2011;38(5):1012-8.
2011: Onno M Mets; Matthijs Oudkerk; Mathias Prokop; Bram van Ginneken; Rob J van Klaveren; Rozemarijn Vliegenthart; Pieter Zanen; Harry J de Koning; Hester A Gietema; Ivana Isgum; Jan-Willem J Lammers; Willem P Th M Mali; Constantinus F M Buckens; Pim A de Jong
Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.
JAMA : the journal of the American Medical Association 2011;306(16):1775-81.
2011: Susan C van't Westeinde; Rene Vernhout; Carla Weenink; Harry J de Koning; Harry J M Groen; Jan-Willem J Lammers; Willem Mali; Kristiaan Nackaerts; Matthijs Oudkerk; Frederik B Thunnissen; Rob J van Klaveren
The role of the ¹⁸f-fluorodeoxyglucose-positron emission tomography scan in the Nederlands Leuvens Longkanker screenings Onderzoek lung cancer screening trial.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(10):1704-12.
2011: Rob J van Klaveren
Lung cancer screening.
European journal of cancer (Oxford, England : 1990) 2011;47 Suppl 3():S147-55.
2011: Rob J van Klaveren
Chairperson's introduction: The goal of cancer screening is to detect cancer when it is early and treatable, if not curable.
European journal of cancer (Oxford, England : 1990) 2011;47 Suppl 3():S132.
2011: Firdaus A A Mohamed Hoesein; Christian Mol; Dirkje S Postma; Mathias Prokop; Bram van Ginneken; Rob J van Klaveren; Pieter Zanen; H Marike Boezen; Bartjan de Hoop; Akkelies E Dijkstra; Hester A Gietema; Harry J M Groen; Ivana Isgum; Cas L J J Kruitwagen; Jan-Willem J Lammers
CT-quantified emphysema in male heavy smokers: association with lung function decline.
Thorax 2011;66(9):782-7.
2011: K A M van den Bergh; Rob J van Klaveren; Gerard J J M Borsboom; Marie-Louise Essink-Bot; E T Scholten; Harry J de Koning
Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial.
The European respiratory journal 2011;38(1):154-61.
2011: C M van der Aalst; Rob J van Klaveren; K A M van den Bergh; Marc C Willemsen; Harry J de Koning
The impact of a lung cancer computed tomography screening result on smoking abstinence.
The European respiratory journal 2011;37(6):1466-73.
2011: Rob J van Klaveren
Is CT screening for lung cancer ready for prime time?
Journal of thoracic imaging 2011;26(1):4-5.
2011: Susan C Van't Westeinde; Rob J van Klaveren
Screening and early detection of lung cancer.
Cancer journal (Sudbury, Mass.) 2011;17(1):3-10.
2010: Karien A M van den Bergh; Marie-Louise Essink-Bot; Rob J van Klaveren; Harry J de Koning
Informed decision making does not affect health-related quality of life in lung cancer screening (NELSON trial).
European journal of cancer (Oxford, England : 1990) 2010;46(18):3300-6.
2010: Veerle F M Surmont; Egbert F Smit; M de Jonge; Joachim G J V Aerts; Kristiaan Nackaerts; R Vernhout; J Gras; A Van Wijk; E C J Phernambucq; Jan P van Meerbeeck; Suresh Senan; C J Kraaij; N Chouaki; J Praag; Rob J van Klaveren
Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studies.
Lung cancer (Amsterdam, Netherlands) 2010;69(3):302-6.
2010: Noëlle C van der Voort van Zyp; Bronno van der Holt; Rob J van Klaveren; Peter Pattynama; Alex P W M Maat; Joost J Nuyttens
Stereotactic body radiotherapy using real-time tumor tracking in octogenarians with non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2010;69(3):296-301.
2010: C M van der Aalst; Rob J van Klaveren; Harry J de Koning
Does participation to screening unintentionally influence lifestyle behaviour and thus lifestyle-related morbidity?
Best practice & research. Clinical gastroenterology 2010;24(4):465-78.
2010: Carlijn Michelle van der Aalst; Karien Anna Margaretha van den Bergh; Marc C Willemsen; Henricus Johannes de Koning; Rob J van Klaveren
Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial.
Thorax 2010;65(7):600-5.
2010: Eleonora Baecke; Harry J de Koning; Suzie J Otto; Carola A van Iersel; Rob J van Klaveren
Limited contamination in the Dutch-Belgian randomized lung cancer screening trial (NELSON).
Lung cancer (Amsterdam, Netherlands) 2010;69(1):66-70.
2010: Dominique de Costa; Ingrid Broodman; Martijn M VanDuijn; Christoph Stingl; Lennard Dekker; Peter C Burgers; Henk C Hoogsteden; Peter A E Sillevis Smitt; Rob J van Klaveren; Theo M Luider
Sequencing and quantifying IgG fragments and antigen-binding regions by mass spectrometry.
Journal of proteome research 2010;9(6):2937-45.
2010: Ying Wang; Geertruida H de Bock; Rob J van Klaveren; Peter van Ooijen; Wim Tukker; Yingru Zhao; Monique D Dorrius; Rozemarijn Vliegenthart Proença; Wendy J Post; Matthijs Oudkerk
Volumetric measurement of pulmonary nodules at low-dose chest CT: effect of reconstruction setting on measurement variability.
European radiology 2010;20(5):1180-7.
2010: Noëlle C van der Voort van Zyp; Jean-Briac Prévost; Bronno van der Holt; Cora Braat; Rob J van Klaveren; Peter M T Pattynama; Peter C Levendag; Joost J Nuyttens
Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer.
International journal of radiation oncology, biology, physics 2010;77(1):31-7.
2010: Peter C Jacobs; Mathias Prokop; Yolanda van der Graaf; Martijn J Gondrie; Kristel J Janssen; Harry J de Koning; Ivana Isgum; Rob J van Klaveren; Matthijs Oudkerk; Bram van Ginneken; Willem P Mali
Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in a high-risk population of heavy smokers.
Atherosclerosis 2010;209(2):455-62.
2010: K A M van den Bergh; Marie-Louise Essink-Bot; Gerard J J M Borsboom; E Th Scholten; Mathias Prokop; Harry J de Koning; Rob J van Klaveren
Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON).
British journal of cancer 2010;102(1):27-34.
2010: Veerle F M Surmont; Joachim G J V Aerts; Rob J van Klaveren; K Tournoy; KY Tan; R M Vernhout; P I M Schmitz; C Legrand; Henk C Hoogsteden; Jan P van Meerbeeck
A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer.
Oncology 2010;78(3-4):267-70.
2010: Hester A Gietema; Pieter Zanen; Arnold Schilham; Bram van Ginneken; Rob J van Klaveren; Mathias Prokop; Jan-Willem J Lammers
Distribution of emphysema in heavy smokers: impact on pulmonary function.
Respiratory medicine 2010;104(1):76-82.
2009: Rob J van Klaveren; Matthijs Oudkerk; Mathias Prokop; Ernst T Scholten; Kristiaan Nackaerts; Rene Vernhout; Carola A van Iersel; Karien A M van den Bergh; Susan van 't Westeinde; Carlijn van der Aalst; Erik Thunnissen; Dong Ming Xu; Ying Wang; Yingru Zhao; Hester A Gietema; Bart-Jan de Hoop; Harry J M Groen; Geertruida H de Bock; Peter van Ooijen; Carla Weenink; Johny Verschakelen; Jan-Willem J Lammers; Wim Timens; Dik Willebrand; Aryan Vink; Willem Mali; Harry J de Koning
Management of lung nodules detected by volume CT scanning.
The New England journal of medicine 2009;361(23):2221-9.
2009: Veerle F M Surmont; Joachim G J V Aerts; E Pouw; KY Tan; R Vernhout; J Gras; J Salomé; T Pronk; P I M Schmitz; Henk C Hoogsteden; Rob J van Klaveren
Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: a non-randomized phase II study.
Lung cancer (Amsterdam, Netherlands) 2009;66(3):333-7.
2009: Rob J van Klaveren
Lung cancer screening with low dose computed tomography: where do we stand today?
European journal of cancer (Oxford, England : 1990) 2009;45 Suppl 1():375-6.
2009: K A M van den Bergh; Marie-Louise Essink-Bot; Rob J van Klaveren; Harry J de Koning
Informed participation in a randomised controlled trial of computed tomography screening for lung cancer.
The European respiratory journal 2009;34(3):711-20.
2009: Noëlle C van der Voort van Zyp; Jean-Briac Prévost; Mischa S Hoogeman; John Praag; Bronno van der Holt; Peter C Levendag; Rob J van Klaveren; Peter Pattynama; Joost J Nuyttens
Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;91(3):296-300.
2009: Dong Ming Xu; Rob J van Klaveren; Geertruida H de Bock; Anne L M Leusveld; Monique D Dorrius; Yingru Zhao; Ying Wang; Harry J de Koning; Ernst T Scholten; Johny Verschakelen; Mathias Prokop; Matthijs Oudkerk
Role of baseline nodule density and changes in density and nodule features in the discrimination between benign and malignant solid indeterminate pulmonary nodules.
European journal of radiology 2009;70(3):492-8.
2009: P M B van Tilburg; H Stam; Henk C Hoogsteden; Rob J van Klaveren
Pre-operative pulmonary evaluation of lung cancer patients: a review of the literature.
The European respiratory journal 2009;33(5):1206-15.
2009: Veerle F M Surmont; Joachim G J V Aerts; KY Tan; Franz Schramel; R Vernhout; Henk C Hoogsteden; Rob J van Klaveren
Non-Cross Resistant Sequential Single Agent Chemotherapy in First-Line Advanced Non-Small Cell Lung Cancer Patients: Results of a Phase II Study.
Journal of oncology 2009;2009():457418.
2008: Eveline M Bunge; Karien A M van den Bergh; Marie-Louise Essink-Bot; Rob J van Klaveren; Harry J de Koning
High affective risk perception is associated with more lung cancer-specific distress in CT screening for lung cancer.
Lung cancer (Amsterdam, Netherlands) 2008;62(3):385-90.
2008: Dong Ming Xu; Rob J van Klaveren; Geertruida H de Bock; Anne Leusveld; Yingru Zhao; Ying Wang; Rozemarijn Vliegenthart; Harry J de Koning; Ernst T Scholten; Johny Verschakelen; Mathias Prokop; Matthijs Oudkerk
Limited value of shape, margin and CT density in the discrimination between benign and malignant screen detected solid pulmonary nodules of the NELSON trial.
European journal of radiology 2008;68(2):347-52.
2008: Ying Wang; Rob J van Klaveren; Hester J van der Zaag-Loonen; Geertruida H de Bock; Hester A Gietema; Dong Ming Xu; Anne L M Leusveld; Harry J de Koning; Ernst T Scholten; Johny Verschakelen; Mathias Prokop; Matthijs Oudkerk
Effect of nodule characteristics on variability of semiautomated volume measurements in pulmonary nodules detected in a lung cancer screening program.
Radiology 2008;248(2):625-31.
2008: Karien A M van den Bergh; Marie-Louise Essink-Bot; Eveline M Bunge; Ernst Th Scholten; Mathias Prokop; Carola A van Iersel; Rob J van Klaveren; Harry J de Koning
Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial).
Cancer 2008;113(2):396-404.
2008: Paul Taylor; Bruno Castagneto; Graham Dark; Maurizio Marangolo; Giorgio V Scagliotti; Rob J van Klaveren; Roberto Labianca; Monika Serke; W Schuette; Jan P van Meerbeeck; David Heigener; Yushan Liu; Susumu Adachi; Johannes Blatter; Joachim von Pawel
Single-agent pemetrexed for chemonaïve and pretreated patients with malignant pleural mesothelioma: results of an International Expanded Access Program.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(7):764-71.
2008: Susan C van't Westeinde; Harry J de Koning; Dong-Ming Xu; Henk C Hoogsteden; Rob J van Klaveren
How to deal with incidentally detected pulmonary nodules less than 10mm in size on CT in a healthy person.
Lung cancer (Amsterdam, Netherlands) 2008;60(2):151-9.
2008: Berend C Stoel; David G Parr; Els M Bakker; Hein Putter; Jan Stolk; Hester A Gietema; Arnold M Schilham; Bram van Ginneken; Rob J van Klaveren; Jan-Willem J Lammers; Mathias Prokop
Can the extent of low-attenuation areas on CT scans really demonstrate changes in the severity of emphysema?
Radiology 2008;247(1):293-4; author reply 294.
2008: Rob J van Klaveren; Matthijs Oudkerk; W P Th M Mali; Harry J de Koning
[Multi-detector CT screening for lung cancer is still to be discouraged for the time being].
Nederlands tijdschrift voor geneeskunde 2008;152(3):125-8.
2007: Hester A Gietema; Arnold M R Schilham; Bram van Ginneken; Rob J van Klaveren; Jan-Willem J Lammers; Mathias Prokop
Monitoring of smoking-induced emphysema with CT in a lung cancer screening setting: detection of real increase in extent of emphysema.
Radiology 2007;244(3):890-7.
2007: J C M van de Wiel; Y Wang; D M Xu; H J van der Zaag-Loonen; E J van der Jagt; Rob J van Klaveren; Matthijs Oudkerk
Neglectable benefit of searching for incidental findings in the Dutch-Belgian lung cancer screening trial (NELSON) using low-dose multidetector CT.
European radiology 2007;17(6):1474-82.
2007: Carola A van Iersel; Harry J de Koning; Gerrit Draisma; W P Th M Mali; Ernst Th Scholten; Kristiaan Nackaerts; Mathias Prokop; J Dik F Habbema; Mathijs Oudkerk; Rob J van Klaveren
Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON).
International journal of cancer. Journal international du cancer 2007;120(4):868-74.
2007: Veerle F M Surmont; Rob J van Klaveren; C Goor; Franz Schramel; Christian Manegold; C Legrand; Paul Van Schil; Jan P van Meerbeeck
Lessons to learn from EORTC study 08981: a feasibility study of induction chemoradiotherapy followed by surgical resection for stage IIIB non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2007;55(1):95-9.
2006: Dong Ming Xu; Hester A Gietema; Harry J de Koning; René Vernhout; Kristiaan Nackaerts; Mathias Prokop; Carla Weenink; Jan-Willem J Lammers; Harry Groen; Matthijs Oudkerk; Rob J van Klaveren
Nodule management protocol of the NELSON randomised lung cancer screening trial.
Lung cancer (Amsterdam, Netherlands) 2006;54(2):177-84.
2006: Hester A Gietema; Ying Wang; Dongming Xu; Rob J van Klaveren; Harry J de Koning; Ernst Scholten; Johny Verschakelen; Gerhard Kohl; Matthijs Oudkerk; Mathias Prokop
Pulmonary nodules detected at lung cancer screening: interobserver variability of semiautomated volume measurements.
Radiology 2006;241(1):251-7.
2006: Joachim G J V Aerts; Veerle F M Surmont; Rob J van Klaveren; KY Tan; Suresh Senan; G van Wijhe; R Vernhout; G T Verhoeven; Henk C Hoogsteden; Jan P van Meerbeeck
A phase II study of induction therapy with carboplatin and gemcitabine among patients with locally advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(6):532-6.
2006: Ozcan Birim; Arie Pieter Kappetein; Rob J van Klaveren; Ad J J C Bogers
Prognostic factors in non-small cell lung cancer surgery.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2006;32(1):12-23.
2006: Debby P M van den Bogaert; Ellen M Pouw; Gerda van Wijhe; René M Vernhout; Veerle F M Surmont; Henk C Hoogsteden; Rob J van Klaveren
Pemetrexed maintenance therapy in patients with malignant pleural mesothelioma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(1):25-30.
2006: Joost J Nuyttens; J-B Prévost; J Praag; Mischa S Hoogeman; Rob J van Klaveren; Peter C Levendag; Peter M T Pattynama
Lung tumor tracking during stereotactic radiotherapy treatment with the CyberKnife: Marker placement and early results.
Acta oncologica (Stockholm, Sweden) 2006;45(7):961-5.
2005: Jan P van Meerbeeck; Rabab Mohamed Gaafar; Christian Manegold; Rob J van Klaveren; Eric A Van Marck; mark vincent; Catherine Legrand; andrew bottomley; Channa Debruyne; Giuseppe Giaccone
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):6881-9.
2005: Leon M van den Toorn; Elsbeth Schaap; Veerle F M Surmont; Ellen M Pouw; Karin C D van der Rijt; Rob J van Klaveren
Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter.
Lung cancer (Amsterdam, Netherlands) 2005;50(1):123-7.
2005: Ozcan Birim; Arie Pieter Kappetein; Tom Goorden; Rob J van Klaveren; Ad J J C Bogers
Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer.
The Annals of thoracic surgery 2005;80(3):1021-6.
2005: Ozcan Birim; Arie Pieter Kappetein; Johanna J M Takkenberg; Rob J van Klaveren; Ad J J C Bogers
Survival after pathological stage IA nonsmall cell lung cancer: tumor size matters.
The Annals of thoracic surgery 2005;79(4):1137-41.
2004: Rob J van Klaveren; Joachim G J V Aerts; Hein de Bruin; Giuseppe Giaccone; Christian Manegold; Jan P van Meerbeeck
Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma.
Lung cancer (Amsterdam, Netherlands) 2004;43(1):63-9.
2003: Albertus N van Geel; Peter P Jansen; Rob J van Klaveren; J R M van der Sijp
High relapse-free survival after preoperative and intraoperative radiotherapy and resection for sulcus superior tumors.
Chest 2003;124(5):1841-6.
2003: Bertien Buyse; Nikolaos Markous; Michel Cauberghs; Rob J van Klaveren; Erik Muls; Maurits Demedts
Effect of obesity and/or sleep apnea on chemosensitivity: differences between men and women.
Respiratory physiology & neurobiology 2003;134(1):13-22.
2002: Rob J van Klaveren; Harry J de Koning; James Mulshine; Fred R Hirsch
Lung cancer screening by spiral CT. What is the optimal target population for screening trials?
Lung cancer (Amsterdam, Netherlands) 2002;38(3):243-52.
2002: Suresh Senan; Sjaak A Burgers; Michael J Samson; Rob J van Klaveren; Swie Swat Oei; John R van Sörnsen de Koste; Peter W J Voet; Frank J Lagerwaard; Jan Maarten van Haarst; Joachim G J V Aerts; Jan P van Meerbeeck
Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy.
International journal of radiation oncology, biology, physics 2002;54(4):999-1006.
2002: Veerle F M Surmont; Rob J van Klaveren; Peter J C M Nowak; pieter zondervan; Henk C Hoogsteden; Jan P van Meerbeeck
Unexpected response of a pulmonary blastoma on radiotherapy: a case report and review of the literature.
Lung cancer (Amsterdam, Netherlands) 2002;36(2):207-11.
2002: Jan P van Meerbeeck; Paul Baas; Channa Debruyne; Egbert F Smit; Rob J van Klaveren; D Galdermans; M A Lentz; Christian Manegold; Giuseppe Giaccone
A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma.
European journal of cancer (Oxford, England : 1990) 2002;38(6):779-83.
2002: J M W van Haarst; Paul Baas; Ch Manegold; J Hugo Schouwink; Jacobus A Burgers; H G de Bruin; W J Mooi; Rob J van Klaveren; M J A de Jonge; Jan P van Meerbeeck
Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma.
British journal of cancer 2002;86(3):342-5.
2001: Rob J van Klaveren; J H Pedersen; Harry J de Koning; M Oudkerk; Henk C Hoogsteden
Lung cancer screening by low-dose spiral computed tomography.
The European respiratory journal 2001;18(5):857-66.
2001: Jan P van Meerbeeck; C Legrand; Rob J van Klaveren; G Giaccone
Chemotherapy for non-small-cell lung cancer.
Lancet 2001;358(9289):1271-2.
2001: Rob J van Klaveren; J D Habbema; Harry J de Koning; M Oudkerk; R A Damhuis; Henk C Hoogsteden
[Screening for lung cancer in the Netherlands: the role of spiral CT scan].
Nederlands tijdschrift voor geneeskunde 2001;145(11):521-6.
1999: Rob J van Klaveren; T Buyse; L Van De Gaer; J Meekers; F Rochette; Maurits Demedts
Micturitional disturbances are associated with impaired breathing control in multiple sclerosis.
Chest 1999;115(6):1539-45.
1999: Rob J van Klaveren; B Nemery
Role of reactive oxygen species in occupational and environmental obstructive pulmonary diseases.
Current opinion in pulmonary medicine 1999;5(2):118-23.
1998: Rob J van Klaveren; Maurits Demedts
Determinants of the hypercapnic and hypoxic response in normal man.
Respiration physiology 1998;113(2):157-65.
1998: Rob J van Klaveren; Maurits Demedts
A mathematical and physiological evaluation of the different hypoxic response models in normal man.
Respiration physiology 1998;113(2):123-33.